What is the share price of Jupiter Life Line Hospitals Ltd (JLHL) today?
The share price of JLHL as on 20th March 2025 is ₹1634.75. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Jupiter Life Line Hospitals Ltd (JLHL) share?
The past returns of Jupiter Life Line Hospitals Ltd (JLHL) share are- Past 1 week: 1.77%
- Past 1 month: 5.92%
- Past 3 months: 1.10%
- Past 6 months: 16.06%
- Past 1 year: 36.83%
- Past 3 years: N/A%
- Past 5 years: 49.57%
What are the peers or stocks similar to Jupiter Life Line Hospitals Ltd (JLHL)?
The peers or stocks similar to Jupiter Life Line Hospitals Ltd (JLHL) include:What is the dividend yield % of Jupiter Life Line Hospitals Ltd (JLHL) share?
The current dividend yield of Jupiter Life Line Hospitals Ltd (JLHL) is 0.06.What is the market cap of Jupiter Life Line Hospitals Ltd (JLHL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Jupiter Life Line Hospitals Ltd (JLHL) is ₹10412.54 Cr as of 20th March 2025.What is the 52 week high and low of Jupiter Life Line Hospitals Ltd (JLHL) share?
The 52-week high of Jupiter Life Line Hospitals Ltd (JLHL) is ₹1706.25 and the 52-week low is ₹1067.65.What is the PE and PB ratio of Jupiter Life Line Hospitals Ltd (JLHL) stock?
The P/E (price-to-earnings) ratio of Jupiter Life Line Hospitals Ltd (JLHL) is 58.96. The P/B (price-to-book) ratio is 8.91.Which sector does Jupiter Life Line Hospitals Ltd (JLHL) belong to?
Jupiter Life Line Hospitals Ltd (JLHL) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Jupiter Life Line Hospitals Ltd (JLHL) shares?
You can directly buy Jupiter Life Line Hospitals Ltd (JLHL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Jupiter Life Line Hospitals Ltd
JLHL Share Price
1,634.752.94% (+46.65)
JLHL Share Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
JLHL Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
JLHL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 53.70 | 8.91 | 0.06% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 48.65 | 6.21 | 0.55% |
JLHL Analyst Ratings & Forecast
Detailed Forecast 80%
Analysts have suggested that investors can buy this stock
from 5 analysts
Price Upside
Earnings Growth
Rev. Growth
JLHL Company Profile
Jupiter Life Line Hospitals Ltd operates multi-specialty hospitals in India, offering over 30 specialty treatments and promoting medical tourism.
Investor Presentation
View olderJLHL Similar Stocks (Peers)
Compare with peersMAXHEALTH
PE Ratio
99.95
1Y Return
47.98%
Buy Reco %
73.68
APOLLOHOSP
PE Ratio
102.85
1Y Return
5.14%
Buy Reco %
86.21
FORTIS
PE Ratio
76.88
1Y Return
52.44%
Buy Reco %
100.00
PE Ratio
42.33
1Y Return
34.47%
Buy Reco %
66.67
MEDANTA
PE Ratio
91.38
1Y Return
1.45%
Buy Reco %
71.43
JLHL Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
JLHL Stock Summary · November 2024
The company has demonstrated robust financial growth, with a 22.7% increase in total income and a remarkable 52.9% rise in profit after tax for Q2 FY25, driven by a favorable market environment and increasing insurance penetration. However, operational challenges persist, particularly in managing occupancy rates and integrating new facilities in Indore and Pune, which have impacted EBITDA margins currently at 23.6%. Despite these hurdles, the strategic expansion into regions with a significant healthcare gap is underway, with new beds being added to meet rising demand. Anticipated regulatory approvals for the Pune facility are crucial for future growth, as the company aims to enhance service quality and achieve an EBITDA margin of around 25% amidst ongoing capacity expansion efforts. Overall, the outlook remains positive, with expectations of increased healthcare consumption as patients seek higher quality services.
Key Points on JLHL Stock Performance
JLHL Stock Growth Drivers
5Strong Financial Performance
Jupiter Life Line Hospitals has reported significant financial growth in Q2 and H1 FY25. For
Increased Operational Capacity
The company has successfully increased its operational capacity, with an occupancy rate of 67.2% in
JLHL Stock Challenges
4Operational Performance Challenges
The company is currently facing challenges in operational performance, particularly highlighted by a low occupancy
Flat EBITDA Margins Despite Revenue Growth
Despite achieving a 23% revenue growth, the company is experiencing flat EBITDA margins. The current
JLHL Forecasts
Price
Revenue
Earnings
JLHL Share Price Forecast
2024
Current
₹1,588.10
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2024
Current
₹1,588.10
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
JLHL Company Revenue Forecast
2024
Current
₹1.10
Baseline
Forecast for Mar 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2024
Current
₹1.10
Baseline
Forecast for Mar 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
JLHL Stock EPS (Earnings Per Share) Forecast
2024
Current
₹28.93
Baseline
Forecast for Mar 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹
2024
Current
₹28.93
Baseline
Forecast for Mar 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹
JLHL
Income
Balance Sheet
Cash Flow
Annual Normal View
JLHL Income Statement
Annual Normal View
| Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 464.84 | 490.27 | 737.14 | 902.96 | 1,095.48 | 1,258.18 | ||||||
Raw Materials | 83.64 | 97.53 | 144.54 | 160.86 | 191.81 | 944.70 | ||||||
| Power & Fuel Cost | 16.04 | 15.76 | 15.62 | 22.84 | 23.37 | |||||||
| Employee Cost | 90.11 | 100.98 | 128.98 | 151.50 | 181.97 | |||||||
| Selling & Administrative Expenses | 126.89 | 137.56 | 204.55 | 253.27 | 308.64 | |||||||
| Operating & Other expenses | 63.67 | 67.17 | 86.25 | 104.96 | 125.56 | |||||||
EBITDA | 84.49 | 71.27 | 157.20 | 209.53 | 264.13 | 313.48 | ||||||
| Depreciation/Amortization | 25.91 | 30.74 | 36.16 | 38.56 | 42.38 | 49.76 | ||||||
| PBIT | 58.58 | 40.53 | 121.04 | 170.97 | 221.75 | 263.72 | ||||||
| Interest & Other Items | 25.69 | 38.98 | 43.94 | 42.27 | 26.34 | 5.91 | ||||||
| PBT | 32.89 | 1.55 | 77.10 | 128.70 | 195.41 | 257.81 | ||||||
| Taxes & Other Items | 3.25 | 3.85 | 25.99 | 55.80 | 18.80 | 63.91 | ||||||
| Net Income | 29.64 | -2.30 | 51.11 | 72.90 | 176.61 | 193.90 | ||||||
| EPS | 5.83 | -0.45 | 10.05 | 13.58 | 28.93 | 29.57 | ||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | ||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.03 |
JLHL Company Updates
JLHL Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Jupiter Life Line Hospitals Ltd | 58.96 | 8.91 | 0.06% |
| Max Healthcare Institute Ltd | 99.95 | 12.57 | 0.14% |
| Apollo Hospitals Enterprise Ltd | 102.85 | 12.62 | 0.25% |
| Fortis Healthcare Ltd | 76.88 | 5.38 | 0.16% |
JLHL Stock Price Comparison
Compare JLHL with any stock or ETFCompare JLHL with any stock or ETF
JLHL
JLHL Shareholdings
JLHL Promoter Holdings Trend
JLHL Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Increased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has increased by 1.20%
JLHL Shareholding Pattern
JLHL Shareholding History
Mutual Funds
Mutual Funds Invested in JLHL
A list of mutual funds holding the stock, ranked on the basis of Market-cap held which is calculated as the value of stock held in the portfolio divided by its market cap
Decreased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has decreased by 1.01%
Top 5 Mutual Funds holding Jupiter Life Line Hospitals Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 3.1547% | Percentage of the fund’s portfolio invested in the stock 1.69% | Change in the portfolio weight of the stock over the last 3 months 0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 50/77 (-1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.3284% | Percentage of the fund’s portfolio invested in the stock 1.38% | Change in the portfolio weight of the stock over the last 3 months 0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 34/58 (-2) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.1031% | Percentage of the fund’s portfolio invested in the stock 3.47% | Change in the portfolio weight of the stock over the last 3 months -0.17% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 9/33 (0) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing JLHL stock
Looks like this stock is not in any smallcase yet.
JLHL Events
JLHL Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
JLHL Upcoming Dividends
No upcoming dividends are available
JLHL Past Dividends
Cash Dividend
Ex DateEx DateAug 2, 2024
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Aug 2, 2024
JLHL Stock News & Opinions
Articles & Videos
Earnings
Jupiter Life Line Hospitals consolidated net profit rises 20.24% in the December 2024 quarter
Net profit of Jupiter Life Line Hospitals rose 20.24% to Rs 52.51 crore in the quarter ended December 2024 as against Rs 43.67 crore during the previous quarter ended December 2023. Sales rose 17.62% to Rs 320.64 crore in the quarter ended December 2024 as against Rs 272.61 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales320.64272.61 18 OPM %23.3922.69 - PBDT80.5368.88 17 PBT66.5658.23 14 NP52.5143.67 20 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Jupiter Life Line Hospitals to announce Quarterly Result
Jupiter Life Line Hospitals will hold a meeting of the Board of Directors of the Company on 7 February 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Jupiter Life Line Hospitals announces addition of capacity at its Indore Hospital
Jupiter Life Line Hospitals announced that an additional 78 beds at Indore Hospital have become operational as of 01 January 2025. As a result, the current capacity of the Company and its subsidiary now stands at 1,061 beds. Powered by Capital Market - Live
2 months agoCapital Market - Live
Spotlight
Jupiter Life rallies after Q2 PAT jumps 53% YoY to Rs 51 cr
Profit before tax (PBT) increased 66.55% to Rs 68.9 crore in Q2 FY25 as compared with Rs 41.4 crore in Q2 FY24. EBITDA stood at Rs 76.6 core in Q2 FY25, registering the growth of 23.5% as compared with Rs 62 crore in Q2 FY24. EBITDA margin was 19.2% in Q2 FY25 as against 19.5% in Q2 FY24. Ankit Thakker ED & CEO, Jupiter Life Line Hospitals, said, 'We are pleased to report a 20.5% increase in total income, reaching Rs 612.8 crore in H1FY25, up from Rs 508.4 crore in H1FY24. EBITDA rose by 22.3% to Rs 141.9 crore, compared to Rs 116.1 crore in H1FY24, while PAT grew by 9.6% to Rs 96.1 crore in H1FY25, up from Rs 87.7 crore in H1FY24. This growth has been driven by strong operational performance across all three hospitals, reflected in higher occupancy rates and increased ARPOB. In Q2FY25, we added 22 beds at our Pune hospital and are in the process of adding 75 new beds at our Indore hospital, which is expected to be operational by Q4FY25. We are focused on expanding the Jupiter brand, enhancing management professionalism, and increasing our footprint. With this regards, the construction of our Dombivli hospital is progressing on schedule. For our Pune hospitals, we are in the advanced stages of obtaining the necessary regulatory approvals. With the addition of these two new facilities, our total bed capacity will increase to around 2,200 beds, and we are currently identifying another location to raise our total capacity to approximately 2,500 beds.' Jupiter Life Line Hospitals is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India. Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Jupiter Life Line Hospitals consolidated net profit rises 52.94% in the September 2024 quarter
Net profit of Jupiter Life Line Hospitals rose 52.94% to Rs 51.51 crore in the quarter ended September 2024 as against Rs 33.68 crore during the previous quarter ended September 2023. Sales rose 22.57% to Rs 322.58 crore in the quarter ended September 2024 as against Rs 263.18 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales322.58263.18 23 OPM %23.2523.19 - PBDT83.3052.76 58 PBT68.9142.14 64 NP51.5133.68 53 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Jupiter Life Line Hospitals to announce Quarterly Result
Jupiter Life Line Hospitals will hold a meeting of the Board of Directors of the Company on 8 November 2024Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Jupiter Life Line Hospitals consolidated net profit declines 17.39% in the June 2024 quarter
Net profit of Jupiter Life Line Hospitals declined 17.39% to Rs 44.61 crore in the quarter ended June 2024 as against Rs 54.00 crore during the previous quarter ended June 2023. Sales rose 18.05% to Rs 287.13 crore in the quarter ended June 2024 as against Rs 243.22 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales287.13243.22 18 OPM %22.2421.79 - PBDT71.1445.84 55 PBT60.1435.12 71 NP44.6154.00 -17 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Jupiter Life Line Hospitals to table results
Jupiter Life Line Hospitals will hold a meeting of the Board of Directors of the Company on 9 August 2024.Powered by Capital Market - Live
7 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant